Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Opsonix

Opsonix?uq=PEM9b6PF
2014 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE (In Progress)
$1.25M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a pathogen-extracting therapy designed to transform the treatment of bloodstream infections and sepsis. The company's pathogen-extracting therapy helps to remove infectious microbes and the toxins released from circulating blood, offering a new broad-spectrum approach, enabling patients with bloodstream infections to improve outcomes and address the greater than 30% mortality rate of patients with sepsis.

Website
Formerly Known As
Opsonix Bio
Ownership Status
Privately Held (backing)
Financing Status
Pending Transaction (VC)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 301 Edgewater Place
  • Suite 100
  • Wakefield, MA 01880
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Opsonix’s full profile, request a free trial.

Opsonix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 27-Oct-2017 $1.25M 00.00 In Progress Generating Revenue
1. Early Stage VC (Series A) 23-Sep-2015 000 000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Opsonix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Opsonix Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Baxter International Corporation Minority 000 0000 000000 0
Baxter Ventures Corporate Venture Capital Minority 000 0000 000000 0
Hansjoerg Wyss Angel (individual) Minority 000 0000 000000 0

Opsonix Executive Team (6)

Name Title Board
Seat
Contact
Info
Eric Devroe Ph.D Founder, Chief Executive Officer & Board Member
Andrew Stevenson Director
Donald Ingber Ph.D Scientific Co-Founder
Michael Super Ph.D Scientific Co-Founder
Greg Martin Ph.D Vice President, Research and Development
You’re viewing 5 of 6 executives. Get the full list »

Opsonix Board Members (3)

Name Representing Role Since Contact
Info
Anne Sissel Baxter Ventures Board Member 000 0000
Brian Pereira MD Self Chairman 000 0000
Eric Devroe Ph.D Opsonix Founder, Chief Executive Officer & Board Member 000 0000